Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United…
- V2ACT Therapeutics™, LLC is a joint venture between Genelux Corporation and TVAX Biomedical, Inc. - V2ACT Immunotherapy is a proprietary immuno-oncology modality composed of…